34results about How to "Avoid overstimulation" patented technology

A sperm collecting apparatus is provided and includes a container including a cylindrical container main unit that has an opening portion on at least one end face in a longitudinal direction thereof and a cap that is attached to and detached from the opening portion of the container main unit to close and open the opening portion, and a core member which is accommodated in said container and has an insertion room extending from an insertion port at one end face in a longitudinal direction therein. The core member includes a core main unit having said insertion port and the insertion room and a plurality of ribs provided upright from an outer face of the core main unit to cross one another, and sealed rooms are formed through the outer face of the core main unit.

The invention discloses a transcranial magnetic stimulation device controlled by near-infrared signals. The TMS stimulation system and the fNIRS signal acquisition system are described above. The present invention utilizes the near-infrared signals of the subjects themselves to set personalized transcranial magnetic stimulation parameters, avoiding excessive stimulation or insufficient stimulation. The present invention is simple and easy to operate, convenient to adjust the transcranial magnetic stimulation parameters according to the real-time near-infrared signal in the transcranial magnetic stimulation, meets the needs of personalized treatment, improves the stimulation curative effect of the transcranial magnetic stimulation, and expands the near-infrared signal The application range of detection provides a new method and practical tool for neuroscience research, detection and treatment.

The invention relates to a pre-stimulating stem cell as well as a preparation method and application thereof. The preparation method comprises the following steps of selecting non-target stem cells asauxiliary cells; inducing the auxiliary cells for pyroptosis; obtaining pyroptosis cells, secreta of pyroptosis cells and/or extracts of the pyroptosis cells for culturing stem cells. The preparationmethod provided by the invention can be used for obtaining the stem cells prestimulated by the secreta of the pyroptosis cells; the stem cells can adapt to the natural inflammatory environment; the restoration capability of the stem cells on the damage region can be improved; the method belongs to new breakthrough in the seed material pretreatment in the tissue engineering field; meanwhile, a feasible scheme is provided for pre-stimulating stem cells and solving the problem of clinic disease treatment.

The invention relates to an electro-acupuncture treatment system based on acupucture point impedance. The system mainly comprises an electro-acupuncture pulse synthesizing and amplifying module, an electro-acupuncture output device, an output pulse voltage sampling module, a circuit current sampling module, an analog-digital conversion module, a synchronous module, a data processing module and a working state display module. The system directly samples a human body resistance circuit formed by the electro-acupuncture output device. On the premise of not increasing extract acupoint surface skin detection electrodes and not changing existing operations of an acupuncturist, accurate data of a patient subjected to electro-acupuncture stimulation in an electro-acupuncture treatment process can be directly obtained. Therefore, interference caused by skin surface detection can be effectively avoided, the monitoring and control accuracy of the electro-acupuncture stimulation data is improved, the treatment dosage is defined, and the specific treatment state is acquired in real time. Meanwhile, the system provided by the invention further can determine the distributing range of effective subcutaneous acupoint space according to the measured data change rule, so that the acupuncture positioning and electro-acupuncture treatment precisions are further increased, thereby providing a data ground for clinical researches.

The invention discloses estrus and pregnancy promoting feedstuff for forest female musk deer. The estrus and pregnancy promoting feedstuff is made of rehmannia glutinosa, seeds of Chinese dodder, cyperus rotundus, herba lycopi, patrinia and cornstarch. After a first estrus cycle is ended, the non-pregnant forest female musk deer which are not impregnated are fed with the estrus and pregnancy promoting feedstuff, the pregnant rate of the female musk deer can be increased. The invention further provides a method for female musk deer breeding by the utilization of the estrus and pregnancy promoting feedstuff. According to the method, the non-pregnant forest female musk deer after the first estrus cycle are fed with the estrus and pregnancy promoting feedstuff, illumination time and temperature of the living environment of the female musk deer which are not impregnated are controlled, regular changes of temperature and illumination are made, the temperature is gradually lowered, the illumination time is gradually shortened, and then the pregnancy rate of the female musk deer is obviously increased.

Provided is a bladder automatic urinating system guided by ultrasonic three-dimensional images. The bladder automatic urinating system comprises a three-dimensional ultrasonic probe used for acquiring bladder three-dimensional data in real time, a power supply module used for supplying power to the system, a first field programmable gate array (FPGA) connected with the three-dimensional ultrasonic probe, a second FPGA connected with the first FPGA and a temperature sensing device arranged on an electrode array module and used for monitoring electrode temperature in real time, pulse amplifying units connected with the output of the second FPGA, an electrode array module connected with the output ends of the pulse amplifying unit, and a treatment information saving module connected with the second FPGA. The bladder automatic urinating system accurately positions the position of a bladder with the ultrasonic three-dimensional images, determines the position of a detrusor and the position of an external urethral sphincter according to physiological structure, and stimulates the detrusor and the external urethral sphincter with pulses in different frequencies and amplitudes so as to stimulate the bladder to complete a urinating process accurately and noninvasively under the ultrasonic three-dimensional guidance.

The invention relates to a method and a control device (2) for operating an electrically controllable technical device (1), in particular a machine, an installation, a unit or a technical process. A control panel (4) having input means (6) for issuing control commands to the technical device (1) and for inputting data to the control device (T) from an operator (7) is provided in this case. This control panel (4) also comprises a graphics-enabled output means (8) for displaying subsets of information which is available overall for an operator (7). The important factor here is to provide at least one second screen layout which is designed to display a second subset of information on the graphics-enabled output means (8) and is intended to be viewed from a relatively great distance, in particular from outside an immediate control range (9) of the control panel (4) or the technical device (1). Furthermore, the presence and/or absence of a person in the immediate control range (9) of the control panel (4) or the technical device (1) is detected automatically and automated changeover between a first screen layout and the second screen layout is effected on the basis of the determined state relating to the presence and/or absence of a person in the immediate control range (9) of the control panel (4) or the technical device (1).

The invention relates to a composition(namely an S-3 sebaceous balancing component (SeboTune-3Complex)) for controlling and balancing oil on the skin, wherein the composition contains the components of 0.001-5.0wt% of BUTYLAVOCADATE, 0.001-5.0wt% of Butylene Glycol/Enatia Chlorantha Bark Ectract/Oleanolic Acid, 0.001-5.0wt% of Lecithin/Alcohol/Water and an effective quantity of a cosmetically acceptable carrier. The invention further relates to a preparation method of the composition. The S-3 oil control and balancing composite compound (SeboTune-3Complex) for cosmetics is a particular sebaceous balancing component which is researched by the Mentholatum Company by applying a modern biotechnology and comprehensively taking safety and high efficiency of active ingredients and characteristic of complementary advantages into account, in which three types of high-efficient active ingredients are carefully chosen to prepare the S-3 sebaceous balancing component, and the S-3 sebaceous balancing component has multiple effects of long-acting oil control, shrinkage of enlarged pores, moisture preservation and the like.

The invention belongs to the biomedical engineering field, in particular relating to a surgical biological patch and a preparation method thereof. The surgical biological patch takes a decellation technology as the basis and a biological source epithelial tissue material as a raw material, is mainly applicable to the stanching and the air leakage prevention of a lung wound surface after a thoracic surgery operation, and can be used for the stanching of wound surfaces of various parenchymal viscera (such as livers, spleens and so on).

The inventiondiscloses a method for adding eye protecting light to a display screen. The method comprises steps as follows: soft light is produced in a front area between an effective display area outer frame of a display screen of an electronic product and a product outer contour line, light sources are arranged on the periphery of the side edge of the electronic product, so that an area in the vision range outside the product outer contour line is illuminated, light and shade contrast of light rays of the display screen in the vision range and the periphery of the display screen is relieved, eye fatigue is relieved, and the eye protecting effect is realized. According to the method, transitionbackground light sources are arranged on the periphery of the display screen, so that excessive irritation of local light of the display screen to eyes is avoided, and the eye protecting effect is realized; a part for producing the light sources is designed on the electronic product, a protective case or another type of a covering material combined with the product for use and is integratedwith the original product very well, and other independentlightsources are not needed; besides, the part cannot change with movement and angle change of the product during using.

The invention discloses a pressure measurer for stomach pressure method examination of diabetic gastroparesis patients, which comprises a recorder, a display screen is embedded in the front surface of the recorder, a control box is mounted below the recorder, and the right side of the control box is slidably connected with a telescopic plate; the telescopic adjuster is fixed to the upper surface of the right end of the telescopic plate, a shaping hose is installed on the right side of the telescopic adjuster, a threaded connector is in threaded connection with the outer side of the lower end of the shaping hose, a detection sleeve is integrally connected to the lower end of the threaded connector, and a positioning balloon is installed on the outer side of the lower end of the detection sleeve. A detection inner pipe is installed in the lower end of the detection sleeve in a telescopic mode, and a detection window is formed in the outer side of the lower end of the detection inner pipe. The pressure measuring catheter is provided with the detection sleeve and the detection inner tube, the detection inner tube can be telescopically adjusted relative to the detection sleeve, the problem that the nasal cavity of a patient is rubbed due to the fact that the pressure measuring catheter is integrally telescoped is effectively solved, and damage to the interiors of the noses of the patient can be reduced.

The present invention relates to diltiazem for use as an agent for activating the expression of at least one gene encoding a type III interferon, in the prevention and/or treatment of infections by at least one pathogenic microorganism of the epithelia of the respiratory and/or intestinal tracts.

The present invention describes methods for treating heart diseases by pharmacological manipulation of intrinsic cardiac adrenergic cells. The activation or inhibition of δ-opioid receptors or selective β2-adrenergic receptor agonist in these cells can help regulate catecholamine synthesis and release in these cells. Thus drugs directed towards these receptors can be used in the treatment of heart diseases including acute and chronic congestive heart failure, as well as acute and chronic coronary artery disease. The present invention also describes a method of treating acute decompensated congestive heart failure using δ-opioid receptor agonists or selective β2-adrenergic receptor agonists to stimulate endogenous production of brain natriuretic peptide. This invention also provides a novel strategy for protection against myocardial ischemia through the specific activation of δ-opioid receptors or selective β2-adrenergic receptor agonists exclusively expressed by intrinsic cardiac adrenergic cells in human heart. The activation of intrinsic cardiac adrenergic cells by δ-opioid receptor stimulation enhances endogenous catecholamine release, which subsequently stimulates myocardial alpha 1-adrenoreceptors achieving myocardial protection in patients suffering from myocardial ischemia due to coronary artery disease.